In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease

por Ram, Thrigulla Saketh, Munikumar, Manne, Raju, Vankudavath Naik, Devaraj, Parasannanavar, Boiroju, Naveen Kumar, Hemalatha, Rajkumar, Prasad, P.V.V., Gundeti, Manohar, Sisodia, Brijesh S., Pawar, Sharad, Prasad, G.P., Chincholikar, Mukesh, Goel, Sumeet, Mangal, Anupam, Gaidhani, Sudesh, Srikanth, N., Dhiman, K.S.
Publicado en J Ayurveda Integr Med (2022)